|
PPP4R1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 8.90050000035281E-07 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.23520000006039E-07 |
| Normal-vs-Stage2 |
3.938800E-01 |
| Normal-vs-Stage3 |
1.663960E-03 |
| Normal-vs-Stage4 |
3.975100E-03 |
| Stage1-vs-Stage2 |
1.241870E-02 |
| Stage1-vs-Stage3 |
1.551630E-01 |
| Stage1-vs-Stage4 |
4.468000E-01 |
| Stage2-vs-Stage3 |
1.442230E-01 |
| Stage2-vs-Stage4 |
1.269560E-01 |
| Stage3-vs-Stage4 |
7.568000E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.51390000050434E-07 |
| Normal-vs-AfricanAmerican |
8.538700E-03 |
| Normal-vs-Asian |
5.920699999995E-05 |
| Caucasian-vs-AfricanAmerican |
4.951800E-01 |
| Caucasian-vs-Asian |
7.067700E-02 |
| AfricanAmerican-vs-Asian |
5.999400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.55680000000413E-05 |
| Normal-vs-Female |
4.37630000005296E-06 |
| Male-vs-Female |
4.749200E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.02010000446739E-08 |
| Normal-vs-Age(41-60Yrs) |
6.044400E-04 |
| Normal-vs-Age(61-80Yrs) |
8.377600E-02 |
| Normal-vs-Age(81-100Yrs) |
4.604300E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.577800E-03 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.553690E-04 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.017200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.632240E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.433200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.379400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.798140E-02 |
| Classical-VS-Follicular |
1.28341781646668E-13 |
| Classical-VS-Other |
1.399810E-01 |
| Classical-VS-Normal |
1.08089981409876E-10 |
| Tall-VS-Follicular |
5.097200E-03 |
| Tall-VS-Other |
5.551000E-01 |
| Tall-VS-Normal |
1.823980E-02 |
| Follicular-VS-Other |
3.605000E-01 |
| Follicular-VS-Normal |
3.196400E-01 |
| Other-VS-Normal |
6.626600E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.357870E-02 |
| Normal-vs-N1 |
3.586300E-04 |
| N0-vs-N1 |
3.102300E-02 |
|
|
